Connect Sign InNew Guidelines for the Diagnosis of Diabetes Mellitus
The prevalence of diabetes mellitus continues to increase worldwide. A number of complications including kidney disease, blindness, amputations, and cardiovascular disease are associated with poor glycemic control. Importantly, our healthcare system has many opportunities to improve the medical management of patients with diabetes mellitus.
This session will provide an overview of diabetes mellitus prevalence and diagnosis. Currently used markers for the diagnosis and monitoring of diabetic patients will be discussed. Hemoglobin A1c will be highlighted, along with its use as outlined in the recently published American Diabetes Association guidelines for the diagnosis and management of diabetes mellitus.
Dr. Straseski is a medical director of endocrinology at ARUP and an assistant professor of pathology at the University of Utah School of Medicine. She received her PhD in pathology and laboratory medicine and a master of science in bacteriology from the University of Wisconsin-Madison, where she also served as a postdoctoral associate in the Department of Pathology. Dr. Straseski completed a postdoctoral fellowship in clinical chemistry at the Johns Hopkins Medical Institutions in Baltimore, Maryland. She has previously been awarded the Past-Presidents' Scholarship by the American Association for Clinical Chemistry, as well as a Distinguished Abstract Award from the National Academy of Clinical Biochemistry. Dr. Straseski is board certified in clinical chemistry by the American Board of Clinical Chemistry.
